Loading view.
Industry Symposium
Academy for Cancer Education (ACE) Asia Pacific Lung Cancer Symposium: Emerging Strategies in EGFR Driver Mutation-Based Management of Advanced Non-small Cell Lung Cancer (NSCLC)
Hall 405B
Sponsored by by Janssen
Industry Symposium
Past, Present, and Future of Personalized Care in Lung Cancer: HER2 and DLL3 Targeted Therapies in Focus
Hall 405A
Sponsored by Boehringer Ingelheim
Industry Symposium
Maximising the Potential in ALK+ NSCLC: Enhancing Outcomes and Improving Patient Care
Hall 405C
Sponsored by Pfizer
Industry Symposium
Transforming Care for Patients with Advanced Lung Cancer
Hall 405C
Sponsored by Amgen
Industry Symposium
The Road Ahead: Navigating Developments in Resectable NSCLC
Hall 405B
Sponsored by AstraZeneca
Industry Symposium
A Spotlight on Tumor Treating Fields in Thoracic Oncology
Hall 405C
Sponsored by Novocure
Industry Symposium
Reaching New Heights: Building on the Foundation of Immuno-Oncology
Hall 405B
Sponsored by MSD
Industry Symposium
ADCs in Lung Cancer: Where We Are and Where We Are Going
Hall 406
Sponsored by Daiichi Sankyo, Inc.
Industry Symposium
The Path to Optimizing Immunotherapy in Advanced NSCLC
Hall 405C
Sponsored by Regeneron and Sanofi
Industry Symposium
Tailoring Treatment in Metastatic NSCLC: Advances in Targeted Therapy and Post-progression Treatment Options
Hall 405B
Sponsored by AstraZeneca
Industry Symposium
Tackling Unmet Needs for Patients with NSCLC: Latest Scientific Advances & Investigational Approaches
Hall 405B
Sponsored by GSK
Industry Symposium
Taking Aim at HER2-Driven NSCLC
Hall 406
Sponsored by Daiichi Sankyo and AstraZeneca